Mirum Pharmaceuticals Overview
Mirum Pharmaceuticals Target Price
Analysts' average 12-month price target for Mirum Pharmaceuticals is $140.
Get informed when a big investor buys or sells
+ FollowShare Price
$100.87
Average Target Price
$144.22
43% upside
43% upside18 analysts in the last 4 months
High: $185 | Low: $112
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-06 | Robert W. Baird | $123 | 21.9% upside |  |
| 2026-08-06 | Morgan Stanley | $137 | 35.8% upside | |
| 2026-08-06 | RBC Capital | $135 | 33.8% upside | |
| 2026-08-06 | H.C. WainwrightSwayampakula Ramakanth | $140 | 38.8% upside | |
| 2026-07-07 | RBC CapitalLisa Walter | $148 | 46.7% upside | |
| 2026-06-15 | CLSA | $146 | 44.7% upside | |
| 2026-06-11 | Morgan Stanley | $150 | 48.7% upside | |
| 2026-05-19 | Wolfe Research | $145 | 43.7% upside | |
| 2026-05-07 | RBC CapitalJoe Kim | $142 | 40.8% upside | |
| 2026-05-07 | Raymond JamesRyan Deschner | $165 | 63.6% upside | |
| 2026-05-07 | H.C. Wainwright | $185 | 83.4% upside | |
| 2026-05-07 | Evercore ISI | $138 | 36.8% upside | |
| 2026-05-07 | Stifel Nicolaus | $136 | 34.8% upside | |
| 2026-05-07 | Robert W. Baird | $129 | 27.9% upside | |
| 2026-05-05 | Morgan Stanley | $140 | 38.8% upside | |
| 2026-05-04 | H.C. Wainwright | $175 | 73.5% upside | |
| 2026-04-28 | Robert W. BairdBrian Skorney | $112 | 11% upside | |
| 2026-04-27 | H.C. Wainwright | $150 | 48.7% upside | |
| 2026-03-04 | Evercore ISIGavin Clark-Gartner | $126 | 24.9% upside | |
| 2026-02-26 | Leerink PartnersMani Foroohar | $118 | 17% upside | |
| 2026-02-26 | RBC CapitalJoe Kim | $128 | 26.9% upside | |
| 2026-02-17 | RBC Capital | $130 | 28.9% upside | |
| 2026-01-26 | H.C. Wainwright | $130 | 28.9% upside | |
| 2026-01-20 | Evercore ISI | $101 | 0.1% upside | |
| 2026-01-13 | H.C. Wainwright | $102 | 1.1% upside | |
| 2026-01-12 | Robert W. Baird | $95 |  5.8% downside | |
| 2025-12-19 | UBS | $140 | 38.8% upside | |
| 2025-12-11 | Raymond JamesSteven Seedhouse | $110 | 9.1% upside | |
| 2025-12-10 | Leerink Partners | $100 | 0.9% downside | |
| 2025-12-09 | Morgan StanleyMichael Ulz | $95 | 5.8% downside | |
| 2025-12-08 | Evercore ISI | $94 | 6.8% downside | |
| 2025-12-08 | Robert W. BairdBrian Skorney | $88 | 12.8% downside | |
| 2025-12-08 | Cantor Fitzgerald | $130 | 28.9% upside | |
| 2025-11-05 | Cantor Fitzgerald | $95 | 5.8% downside | |
| 2025-11-05 | H.C. WainwrightSwayampakula Ramakanth | $81 | 19.7% downside | |
| 2025-11-05 | JMP Securities | $95 | 5.8% downside | |
| 2025-10-16 | Morgan Stanley | $81 | 19.7% downside | |
| 2025-08-11 | Stifel NicolausJames Condulis | $89 | 11.8% downside | |
| 2025-08-07 | JMP SecuritiesJonathan Wolleben | $81 | 19.7% downside | |
| 2024-11-12 | Stifel NicolausDae Gon Ha | $70 | 30.6% downside | |
| 2024-08-08 | Robert W. BairdBrian Skorney | $44 | 56.4% downside | |
| 2024-06-17 | Evercore ISIGavin Clark-Gartner | $62 | 38.5% downside | |
| 2024-06-17 | Morgan StanleyMichael E Ulz | $57 | 43.5% downside | |
| 2024-06-17 | H.C. WainwrightEd Arce | $66 | 34.6% downside | |
| 2024-06-17 | Robert W. BairdBrian Skorney | $39 | 61.3% downside | |
| 2024-05-23 | Cantor FitzgeraldJoshua Schimmer | $45 | 55.4% downside | |
| 2024-04-16 | Stifel NicolausDae Gon Ha | $48 | 52.4% downside | |
| 2024-03-14 | H.C. WainwrightEd Arce | $58 | 42.5% downside | |
| 2023-01-10 | Leerink Partners | $39 | 61.3% downside | |
| 2022-12-14 | Leerink Partners | $50 | 50.4% downside | |